Literature DB >> 27179657

Left ventricular geometry and 24-h blood pressure profile in Cushing's syndrome.

Eleonora Avenatti1, Andrea Rebellato2, Andrea Iannaccone1, Marialberta Battocchio2, Francesca Dassie2, Franco Veglio1, Alberto Milan3, Francesco Fallo2.   

Abstract

Cushing's syndrome (CS) is associated with cardiovascular disease. The impact of the hemodynamic load on left ventricular mass (LVM) in patients with CS is not well known. In fact, the effects of 24-h blood pressure (BP) load and BP circadian rhythm on cardiac structure and function have not been studied. Aim of the present study has thus been to assess the presence of cardiac remodeling in patients with newly diagnosed CS, combining evaluation of cardiac remodeling and assessment of BP burden derived by 24-h ambulatory blood pressure monitoring (ABPM). 25 patients (4 M, 21 F) with CS underwent echocardiography in order to assess cardiac morphology and geometry (relative wall thickness-RWT). As controls, 25 subjects similar for demographic characteristics and 24-h BP were used. CS Patients were similar to controls by age, sex, mean 24-h BP, and body mass index. There was a significant increase in left ventricular mass (LVM; 44.4 ± 14.7 vs. 36.9 ± 10 g/m2.7, p = 0.03) and a significant increase in RWT (0.46 ± 0.07 vs. 0.41 ± 0.08, p = 0.02) in CS patients compared to controls. The prevalence of CS patients with pressure non-dipping profile was greater than that of controls (56 vs. 16 %, p < 0.05), with no significant association with LVM or geometry. 24-h urinary cortisol was not associated with LVM (r = 0.1, p = 0.5) or RWT (r = 0.02, p = 0.89) in the CS group. In conclusion, LVM and the concentric pattern of the left ventricle are relatively independent from 24-h BP load and profile (dipping/non-dipping) in CS patients.

Entities:  

Keywords:  Ambulatory blood pressure/home blood pressure monitor; Cardiac remodeling; Cushing’s syndrome; Dipping profile; Secondary high blood pressure

Mesh:

Year:  2016        PMID: 27179657     DOI: 10.1007/s12020-016-0986-6

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  36 in total

1.  European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults.

Authors:  Eoin O'Brien; Neil Atkins; George Stergiou; Nikos Karpettas; Gianfranco Parati; Roland Asmar; Yutaka Imai; Jiguang Wang; Thomas Mengden; Andrew Shennan
Journal:  Blood Press Monit       Date:  2010-02       Impact factor: 1.444

2.  Increased myocardial fibrosis and left ventricular dysfunction in Cushing's syndrome.

Authors:  Kai Hang Yiu; Nina Ajmone Marsan; Victoria Delgado; Nienke R Biermasz; Eduard R Holman; Johannes W A Smit; Richard A Feelders; Jeroen J Bax; Alberto M Pereira
Journal:  Eur J Endocrinol       Date:  2011-10-17       Impact factor: 6.664

3.  Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

Authors:  J A Staessen; L Thijs; R Fagard; E T O'Brien; D Clement; P W de Leeuw; G Mancia; C Nachev; P Palatini; G Parati; J Tuomilehto; J Webster
Journal:  JAMA       Date:  1999-08-11       Impact factor: 56.272

Review 4.  Extrarenal effects of aldosterone.

Authors:  Aurelie Nguyen Dinh Cat; Frederic Jaisser
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-03       Impact factor: 2.894

5.  Mortality and morbidity in Cushing's syndrome in New Zealand.

Authors:  Mark J Bolland; Ian M Holdaway; Juliet E Berkeley; Sarina Lim; Will J Dransfield; John V Conaglen; Michael S Croxson; Greg D Gamble; Penny J Hunt; Robyn J Toomath
Journal:  Clin Endocrinol (Oxf)       Date:  2011-10       Impact factor: 3.478

6.  Inhibitory effect of glucocorticoid on coronary artery endothelial function.

Authors:  Kestrel M Rogers; Christi A Bonar; Jaymie L Estrella; Shumei Yang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-11       Impact factor: 4.733

Review 7.  Aldosterone, mineralocorticoid receptor, and heart failure.

Authors:  Smail Messaoudi; Feriel Azibani; Claude Delcayre; Frederic Jaisser
Journal:  Mol Cell Endocrinol       Date:  2011-07-18       Impact factor: 4.102

8.  Multisystem morbidity and mortality in Cushing's syndrome: a cohort study.

Authors:  Olaf M Dekkers; Erzsébet Horváth-Puhó; Jens Otto L Jørgensen; Suzanne C Cannegieter; Vera Ehrenstein; Jan P Vandenbroucke; Alberto M Pereira; Henrik Toft Sørensen
Journal:  J Clin Endocrinol Metab       Date:  2013-03-26       Impact factor: 5.958

Review 9.  Inflammation and cortisol response in coronary artery disease.

Authors:  Johnny Nijm; Lena Jonasson
Journal:  Ann Med       Date:  2009       Impact factor: 4.709

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more
  5 in total

1.  Cardiac hypertrophy in Cushing's syndrome: if not hypertension then what?

Authors:  D A Vassiliadi; S Tsagarakis
Journal:  Endocrine       Date:  2017-02-17       Impact factor: 3.633

2.  Clinical Characteristics for the Improvement of Cushing's Syndrome Complicated With Cardiomyopathy After Treatment With a Literature Review.

Authors:  Sisi Miao; Lin Lu; Ling Li; Yining Wang; Zhaolin Lu; Huijuan Zhu; Linjie Wang; Lian Duan; Xiaoping Xing; Yong Yao; Ming Feng; Renzhi Wang
Journal:  Front Cardiovasc Med       Date:  2021-12-01

3.  Deficit of glucocorticoid-induced leucine zipper amplifies angiotensin-induced cardiomyocyte hypertrophy and diastolic dysfunction.

Authors:  Donato Cappetta; Antonella De Angelis; Sara Flamini; Anna Cozzolino; Oxana Bereshchenko; Simona Ronchetti; Eleonora Cianflone; Andrea Gagliardi; Erika Ricci; Concetta Rafaniello; Francesco Rossi; Carlo Riccardi; Liberato Berrino; Stefano Bruscoli; Konrad Urbanek
Journal:  J Cell Mol Med       Date:  2020-11-28       Impact factor: 5.310

4.  The SRSF4-GAS5-Glucocorticoid Receptor Axis Regulates Ventricular Hypertrophy.

Authors:  Javier Larrasa-Alonso; María Villalba-Orero; Carlos Martí-Gómez; Paula Ortiz-Sánchez; Marina M López-Olañeta; M Ascensión Rey-Martín; Fátima Sánchez-Cabo; François McNicoll; Michaela Müller-McNicoll; Pablo García-Pavía; Enrique Lara-Pezzi
Journal:  Circ Res       Date:  2021-08-02       Impact factor: 23.213

5.  Cushing Syndrome Associated Myopathy: It Is Time for a Change.

Authors:  Martin Reincke
Journal:  Endocrinol Metab (Seoul)       Date:  2021-06-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.